Triglyceride-Glucose Index as a Predictor of DiabeticFoot Ulcer Severity in Type 2 Diabetes Mellitus:Cross-Sectional Study
DOI:
https://doi.org/10.66266/inajemd.v2i2.58Keywords:
TyG index, type 2 DM, diabetic foot ulcersAbstract
Introduction: Diabetic foot ulcers are a complication of type 2 diabetes mellitus that has a
high global prevalence. Insulin resistance in type 2 DM patients tends to cause chronic wounds and can delay wound healing. TyG index is currently used as a surrogate biomarker to evaluate insulin resistance because it is easy to perform and low cost.
Methods: Analytic observational research with a cross-sectional approach at Diabetic Foot Poly Ulin Hospital Banjarmasin. The study sample was all patients diagnosed with type 2 DM and undergoing wound care at the Diabetic Foot Polyclinic of Ulin Hospital Banjarmasin starting in December 2024 who met the inclusion and exclusion criteria with a total of at least 74 people. Data analysis was performed with a simple binomial logistic regression test to estimate crude Prevalence Odds Ratio (POR) with 95% confidence intervals, and multiple binomial logistic regression tests were performed to estimate adjusted POR and 95%CIs.
Results: Compared with the lowest one-third TyG Index score, study subjects with the middle
one-third TyG Index score were associated with a lower risk of severe diabetic foot ulcer incidence by 85.9% (Adj POR 0.141, 95% CI: 0.011-1.802). Subjects with the highest third TyG Index value were also associated with a lower risk of diabetic foot ulcer incidence of 87.1% (Adj POR 0.129, 95%CI: 0.008-1.959). The mean value of TyG Index+SD was 4.8872 + 0.4230 at severe foot ulcers.
Conclusion: TyG index is not a predictive factor for the severity of diabetic foot ulcers in type 2 DM patients at the Diabetic Foot Clinic of Ulin Hospital Banjarmasin (p>0.05).
Downloads
References
1. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis†. Vol. 49, Annals of Medicine. Taylor and Francis Ltd; 2017. p. 106–16.
2. Bashmakov YK, Assaad-Khalil S, Petyaev IM. Resveratrol may be beneficial in treatment of diabetic foot syndrome. Med Hypotheses. 2011 Sep;77(3):364–7.
3. Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Vol. 119, Metabolism: Clinical and Experimental. W.B. Saunders; 2021.
4. Rastogi A, Goyal G, Kesavan R, Bal A, Kumar H, Mangalanadanam, et al. Long term outcomes
after incident diabetic foot ulcer: Multicenter large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complications study: Epidemiology of diabetic foot complications study. Diabetes Res Clin Pract. 2020 Apr 1;162.
5. Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Vol. 17, Cardiovascular Diabetology. BioMed Central Ltd.; 2018.
6. Lee SB, Ahn CW, Lee BK, Kang S, Nam JS, You JH, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 2018 Mar 21;17(1).
7. Tao LC, Xu J ni, Wang T ting, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Vol. 21, Cardiovascular Diabetology. BioMed Central Ltd; 2022.
8. Zhang X, Chen W, Wang X, Wu J, Shi W, Wang Wencheng people X, et al. Association between
Triglyceride glucose index and severity of diabetic foot ulcers in type2 diabetes melitus. J
Foot Ankle Res. 2023.
9. Shah P, Inturi R, Anne D, Jadhav D, Viswambharan V, Khadilkar R, et al. Wagner’s Classification as a Tool for Treating Diabetic Foot Ulcers: Our Observations at a Suburban Teaching Hospital. Cureus. 2022 Jan 23
10. Salazar, J., Bermúdez, V., Calvo, M., Olivar, L. C., Luzardo, E., Navarro, C.,Rojas, J. Optimal cutoff
for the evaluation of insulin resistance through triglyceride-glucose index: A cross- sectional
study in a Venezuelan population. 2017.
11. McDermott K, Fang M, Boulton A, Selvin E, Hicks C. Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers.Diabetes Care 2023;46(1):209–221
12. Hicks CW, Canner JK, Mathiodakis N, Lippincott C, Sherman RL, Abularrage CJ. Incidence and
Risk Facctors associated with ulcer recurrent among patients with diabetic foot ulcers treated in a multidisciplinary setting J. Surg Res 2020;246:243-250
13. Rossboth S, Lechleitner M, Oberaigner W. Risk factor for diabetic foot complication in type 2 diabetes-A Systematic review. Endocrinol Diabetes Metab 2020;4:e00175
14. Detty Ade U, The Characteristics of Diabetic Ulcer in Patients with Diabetes Mellitus, jiksh Vol.11 No.1 Juni 2020
15. Zamaun N, Kanang I, Imran M, Iskandar D, Amba EG. Karakteristik Penderita Ulkus Kaki Diabetik. Fakumi Medical Journal: Jurnal Mahasiswa Kedokteran Vol.04 No.04 (April, 2024) E-ISSN:
2808-9146
16. Jalilian M, Sarbarzeh PA, Oubari S. Factors Related to Severity of Diabetic Foot Ulcer: A Systematic Review. Metabolic Syndrome and Obesity, 2020, 1835-1842.
17. Sutkowska E, Sutkowski E, Sokołowski M, Franek E, Dragan S. Distribution of the Highest Plantar Pressure Regions in Patients with Diabetes and Its Association with Peripheral Neuropathy, Gender, Age, and BMI: One Centre Study. Hindawi Journal of Diabetes Research Volume 2019.
18. Nan Xia1, Morteza A, Yang F, Cao H, Wang A. Review of the role of cigarette smoking in diabetic foot. J Diabetes Investig 2019; 10: 202–215.
19. AbdElrahman A. Association Between Smoking and Foot Ulcer among Patients with Diabetes
Mellitus, Wad Medani, Sudan. 2021. Sudan Journal of Medical Sciences, vol. 16, Issue no. 4,pages 450–463.
20. Safari, F. K., Budiharto, I. & Fahdi, F. K. Hubungan Lama Menderita Diabetes Melitus dengan
Kejadian Luka Kaki Berulang di Klinik PKU Muhammadiyah Kitamura Pontianak. Indones. J. Heal. Sci. Volume 15, 1–6 (2023)
21. Ramadani, A. P. et al. Karakteristik Pasien Diabetes Mellitus Tipe 2 dengan Ulkus Diabetik
dan Non Ulkus Diabetik di Rumah Sakit Ibnu Sina Makassar Tahun 2019 - 2021. J. Pendidik.
22. Balakrishnan R, Nagarajan V. Comparative study of insulin with oral antidiabetic drug in Type 2 Diabetik wound healing. Int J Acad Med Pharm. 2023; 5 (2); 394-396
23. O’Dell B, Rothenberg G, Holmes C, Priesand S, Stout K, Brandt E, Brian. The impact of statin
therapy on the healing of diabetic foot ulcers: a case–control series Clinical Diabetes and
Endocrinology (2024) 10:19
24. Nassaji M, Ghorbani R, Shkofte HS. Previous Atorvastatin Treatment and Risk of Diabetic Foot
Infection in Adult Patients: A Case control Study. Wounds. 2017;29(7):196–201
25. Jia H, Wang X, Cheng J. Knowledge, Attitudes, and Practices Associated With Diabetic Foot
Prevention Among Rural Adults With Diabetes in North China. Front Public Health. 2022;10:876105.
26. Liberty IA, Kodim N, Sartika RA, Trihandini I, Zulkarnai, Pane M et al. Triglyceride/Glucose
Index (TyG Index) as a marker of glucose status conversion among reproductive-aged women
in Jakarta, Indonesia: The Bogor cohort study (2011-2016). Diabetes &Metabolic Syndrome: Clinical Research & Reviews 15. 2021; 10228
27. Liberty IA, Putri NK. Association Between Triglyceride-Glucose Index (TyG Index) and Type 2 Diabetes Mellitus: A Systematic Review. Epidemiology Biostatistics and Public Health -
2020, Volume 17, Number 1
Downloads
Published
Issue
Section
License
Copyright (c) 2025 InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright and grant the Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD) the right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
© Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD). Published by the Indonesian Society of Endocrinology (PERKENI).


